Tests MR-guided radiotherapy machine in several types of cancer
Tests imaging and radiotherapy on a new MR-Linac device in adults with cancer.
Plain-language title generated from the registry record
Registry title: Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac
Key facts
- Where
- Tübingen, GermanySee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who already need radiation therapy. It tests imaging and treatment on a new MR-Linac machine.
- Age
- 18 years or older, no upper age limit
- Sex
- All sexes can join.
- Disease stage
- People with an existing indication for radiation therapy. Conditions listed: rectal, head and neck, liver, breast, prostate and esophageal cancer, and oligometastasis.
Main reasons for not taking part
- A reason that rules out MRI (claustrophobia, or metal implants not safe for MRI)
- Pregnancy
Read by machine on 9 November 2026.
Where in Germany
- University Hospital Tübingen, Department of Radiation OncologyTübingen, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital Tuebingen
- Trial code
- NCT04172753
- Record updated
- 21 November 2019
- Original description
This study investigates the feasibility of imaging and treatment on a novel 1.5 T MR-Linac radiotherapy hybrid device.Read full original descriptionShow less
Feasibility of Imaging and Radiotherapy on a Novel 1.5 T Hybrid Magnetic Resonance Imaging - Linear Accelerator System (MR-Linac)
This study investigates the feasibility of imaging and treatment on a novel 1.5 T MR-Linac radiotherapy hybrid device.
Inclusion: existing indication for radiation therapy; minimum age 18 years, no upper age limit; capacity for consent; Informed consent.
Exclusion: contraindication for MRI (claustrophobia, metallic implants not applicable for MRI; pregnancy.